These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of fibrillar C-terminal fragment of cleaved alpha1-antitrypsin on cholesterol homeostasis in HepG2 cells. Janciauskiene S; Lindgren S Hepatology; 1999 Feb; 29(2):434-42. PubMed ID: 9918920 [TBL] [Abstract][Full Text] [Related]
3. Cyclosporine inhibits catabolism of low-density lipoproteins in HepG2 cells by about 25%. Rayyes OA; Wallmark A; Florén CH Hepatology; 1996 Sep; 24(3):613-9. PubMed ID: 8781333 [TBL] [Abstract][Full Text] [Related]
4. Induction of Egr-1 by oncostatin M precedes up-regulation of low density lipoprotein receptors in HepG2 cells. Liu J; Shoyab M; Grove RI Cell Growth Differ; 1993 Jul; 4(7):611-6. PubMed ID: 8398902 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of LDL receptor activity in Hep-G2 cells by a serum factor(s). Ellsworth JL; Brown C; Cooper AD J Cell Physiol; 1988 May; 135(2):213-23. PubMed ID: 2836440 [TBL] [Abstract][Full Text] [Related]
6. Cell density-dependent regulation of cell surface expression of two types of human tumor necrosis factor receptors and its effect on cellular response. Pocsik E; Mihalik R; Ali-Osman F; Aggarwal BB J Cell Biochem; 1994 Apr; 54(4):453-64. PubMed ID: 8014194 [TBL] [Abstract][Full Text] [Related]
7. Midkine protects hepatocellular carcinoma cells against TRAIL-mediated apoptosis through down-regulation of caspase-3 activity. Ohuchida T; Okamoto K; Akahane K; Higure A; Todoroki H; Abe Y; Kikuchi M; Ikematsu S; Muramatsu T; Itoh H Cancer; 2004 Jun; 100(11):2430-6. PubMed ID: 15160348 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor. Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773 [TBL] [Abstract][Full Text] [Related]
9. Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. Maletínská L; Blakely EA; Bjornstad KA; Deen DF; Knoff LJ; Forte TM Cancer Res; 2000 Apr; 60(8):2300-3. PubMed ID: 10786698 [TBL] [Abstract][Full Text] [Related]
10. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters. Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509 [TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of gamma-interferon receptors. Raitano AB; Korc M Cancer Res; 1993 Feb; 53(3):636-40. PubMed ID: 8425199 [TBL] [Abstract][Full Text] [Related]
12. Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity. Noto D; Rizzo M; Barbagallo CM; Cefalù AB; Verde AL; Fayer F; Notarbartolo A; Averna MR Metabolism; 2006 Oct; 55(10):1308-16. PubMed ID: 16979400 [TBL] [Abstract][Full Text] [Related]
13. Curcumin up-regulates LDL receptor expression via the sterol regulatory element pathway in HepG2 cells. Dou X; Fan C; Wo L; Yan J; Qian Y; Wo X Planta Med; 2008 Sep; 74(11):1374-9. PubMed ID: 18704882 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor differentially regulates low density lipoprotein receptor-related protein gene expression in neoplastic and fetal human astrocytes. Hussaini IM; Brown MD; Karns LR; Carpenter J; Redpath GT; Gonias SL; Vandenberg SR Glia; 1999 Jan; 25(1):71-84. PubMed ID: 9888299 [TBL] [Abstract][Full Text] [Related]
15. Reversal of cyclosporine-inhibited low-density lipoprotein receptor activity in HepG2 cells by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. al Rayyes O; Wallmark A; Florén CH Hepatology; 1997 Apr; 25(4):991-4. PubMed ID: 9096609 [TBL] [Abstract][Full Text] [Related]
16. Regulation of low-density lipoprotein receptor activity by estrogens and phytoestrogens in a HepG2 cell model. Owen AJ; Roach PD; Abbey M Ann Nutr Metab; 2004; 48(4):269-75. PubMed ID: 15331887 [TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation. Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868 [TBL] [Abstract][Full Text] [Related]
18. Regulation of low-density lipoprotein metabolism by cell density and proliferative state. Kenagy R; Bierman EL; Schwartz S J Cell Physiol; 1983 Sep; 116(3):404-8. PubMed ID: 6309872 [TBL] [Abstract][Full Text] [Related]
19. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Ting HJ; Stice JP; Schaff UY; Hui DY; Rutledge JC; Knowlton AA; Passerini AG; Simon SI Circ Res; 2007 Feb; 100(3):381-90. PubMed ID: 17234968 [TBL] [Abstract][Full Text] [Related]
20. Complete down-regulation of low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2 by beta-migrating very-low-density lipoprotein and non-lipoprotein cholesterol. Different cellular regulatory pools of cholesterol. Kamps JA; van Berkel TJ Eur J Biochem; 1992 Jun; 206(3):973-8. PubMed ID: 1318843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]